Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to determine the effect and security of low-dose Prednisone
Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis.
Phase:
N/A
Details
Lead Sponsor:
Health Science Center of Xi'an Jiaotong University Health Science Center of Xi’an Jiaotong University